达格列净 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "达格列净" in Chinese language version.

refsWebsite

Global rank Chinese rank

1^st place

447^th place

581^st place

399^th place

208^th place

low place

cfda.gov.cn

Dapagliflozin (Farxiga) Use During Pregnancy. Drugs.com. 30 August 2018 [5 May 2020]. （原始内容存档于2021-04-17）.
Dapagliflozin (Farxiga) Use During Pregnancy. Drugs.com. 30 August 2018 [5 May 2020]. （原始内容存档于2021-04-17）.

Liscinsky, Morgan. FDA approves Farxiga to treat type 2 diabetes. U.S. Food and Drug Administration. Jan 8, 2014 [15 April 2015]. （原始内容存档于2017-02-17）.
Research, Center for Drug Evaluation and. FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes. FDA. 9 February 2019 [2019-11-06]. （原始内容存档于2021-03-08） –通过www.fda.gov.
Safety Alerts for Human Medical Products — SGLT2 inhibitors: Drug Safety Communication — FDA Warns Medicines May Result in a Serious Condition of Too Much Acid in the Blood. Food and Drug Administration. 15 May 2015 [15 November 2016]. （原始内容存档于2017-04-06）（英语）.

Dapagliflozin (Farxiga) Use During Pregnancy. Drugs.com. 30 August 2018 [5 May 2020]. （原始内容存档于2021-04-17）.
Dapagliflozin (Farxiga) Use During Pregnancy. Drugs.com. 30 August 2018 [5 May 2020]. （原始内容存档于2021-04-17）.
Liscinsky, Morgan. FDA approves Farxiga to treat type 2 diabetes. U.S. Food and Drug Administration. Jan 8, 2014 [15 April 2015]. （原始内容存档于2017-02-17）.
中国国家食品药品监督管理总局 2017年度药品审评报告. （原始内容存档于2019-11-06）.
Research, Center for Drug Evaluation and. FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes. FDA. 9 February 2019 [2019-11-06]. （原始内容存档于2021-03-08） –通过www.fda.gov.
Safety Alerts for Human Medical Products — SGLT2 inhibitors: Drug Safety Communication — FDA Warns Medicines May Result in a Serious Condition of Too Much Acid in the Blood. Food and Drug Administration. 15 May 2015 [15 November 2016]. （原始内容存档于2017-04-06）（英语）.